• Profile
Close

Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT

BMC Infectious Diseases Oct 14, 2017

Deng Y, et al. - This study aimed at determining the predictive value of Angiopoietin-like protein 2 (Angptl2) as a novel biomarker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised alanine aminotransferase (ALT). Findings demonstrated that higher Angptl2 level was a potential biomarker that had an independent association with fibrosis stages. Compared with APRI, Hui model, FIB-4, Forn’s index, Angptl2 combined index (ACI) proved better in diagnosing significant fibrosis in hepatitis B patients.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay